Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-022581
Filing Date
2022-11-07
Accepted
2022-11-07 16:02:36
Documents
49
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q prds-20220930.htm   iXBRL 10-Q 2207922
2 EX-31.1 prds-ex31_1.htm EX-31.1 22053
3 EX-31.2 prds-ex31_2.htm EX-31.2 21914
4 EX-32 prds-ex32.htm EX-32 23004
  Complete submission text file 0000950170-22-022581.txt   5361701

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT prds-20220930_lab.xml EX-101.LAB 357304
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT prds-20220930_pre.xml EX-101.PRE 266843
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT prds-20220930_def.xml EX-101.DEF 158659
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT prds-20220930.xsd EX-101.SCH 48231
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT prds-20220930_cal.xml EX-101.CAL 22823
43 EXTRACTED XBRL INSTANCE DOCUMENT prds-20220930_htm.xml XML 474855
Mailing Address 2173 SALK AVENUE SUITE 250, PMB#052 CARLSBAD CA 92008
Business Address 2173 SALK AVENUE SUITE 250, PMB#052 CARLSBAD CA 92008 415-649-8758
PARDES BIOSCIENCES, INC. (Filer) CIK: 0001822711 (see all company filings)

EIN.: 852696306 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40067 | Film No.: 221365357
SIC: 2834 Pharmaceutical Preparations